IL181340D0 - Isolation of stem/progenitor cells from amniotic membrane of umbilical cord - Google Patents

Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

Info

Publication number
IL181340D0
IL181340D0 IL18134007A IL18134007A IL181340D0 IL 181340 D0 IL181340 D0 IL 181340D0 IL 18134007 A IL18134007 A IL 18134007A IL 18134007 A IL18134007 A IL 18134007A IL 181340 D0 IL181340 D0 IL 181340D0
Authority
IL
Israel
Prior art keywords
amniotic membrane
stem
umbilical cord
progenitor cells
isolation
Prior art date
Application number
IL18134007A
Original Assignee
Cellres Corp Pte Ltd
Phan Toan Thang
Lim Ivor Jiun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60220804P priority Critical
Priority to US63220904P priority
Priority to PCT/SG2005/000174 priority patent/WO2006019357A1/en
Application filed by Cellres Corp Pte Ltd, Phan Toan Thang, Lim Ivor Jiun filed Critical Cellres Corp Pte Ltd
Publication of IL181340D0 publication Critical patent/IL181340D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/51Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0605Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0607Non-embryonic pluripotent stem cells, e.g. MASC
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0625Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629Keratinocytes; Whole skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0625Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629Keratinocytes; Whole skin
    • C12N5/063Kereatinocyte stem cells; Keratinocyte progenitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0664Dental pulp stem cells, Dental follicle stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0665Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0666Mesenchymal stem cells from hair follicles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0667Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0668Mesenchymal stem cells from other natural sources
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C12N2506/025Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells from extra-embryonic cells, e.g. trophoblast, placenta
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1392Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from mesenchymal stem cells from other natural sources

Abstract

The present invention relates to stem/progenitor cells isolated from the amniotic membrane of umbilical cord. The isolation method comprises separating the amniotic membrane from the other components of the umbilical cord in vitro, culturing the amniotic membrane tissue under conditions allowing cell proliferation, and isolating the stem/progenitor cells from the tissue cultures. The isolated stem cell cells can have embryonic stem cell-like properties and can be used for various therapeutic purposes.
IL18134007A 2004-08-16 2007-02-14 Isolation of stem/progenitor cells from amniotic membrane of umbilical cord IL181340D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US60220804P true 2004-08-16 2004-08-16
US63220904P true 2004-12-01 2004-12-01
PCT/SG2005/000174 WO2006019357A1 (en) 2004-08-16 2005-06-03 Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.

Publications (1)

Publication Number Publication Date
IL181340D0 true IL181340D0 (en) 2007-07-04

Family

ID=35907673

Family Applications (1)

Application Number Title Priority Date Filing Date
IL18134007A IL181340D0 (en) 2004-08-16 2007-02-14 Isolation of stem/progenitor cells from amniotic membrane of umbilical cord

Country Status (19)

Country Link
US (6) US10363275B2 (en)
EP (2) EP2597149A1 (en)
JP (2) JP5668208B2 (en)
KR (1) KR101322889B1 (en)
AU (1) AU2005273077B2 (en)
BR (1) BRPI0514387A (en)
CA (2) CA2971062C (en)
DK (1) DK1789534T3 (en)
ES (1) ES2527293T3 (en)
GB (1) GB2432166B (en)
HK (1) HK1104061A1 (en)
IL (1) IL181340D0 (en)
MX (1) MX2007001937A (en)
MY (1) MY141772A (en)
NZ (1) NZ553695A (en)
PL (1) PL1789534T3 (en)
RU (1) RU2416638C2 (en)
TW (1) TWI312009B (en)
WO (1) WO2006019357A1 (en)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1272204E (en) * 2000-04-14 2007-10-02 Univ Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
NZ527849A (en) * 2001-02-14 2006-09-29 Anthrogenesis Corp Post-partum mammalian placenta, its use and placental stem cells therefrom
AU2020902A (en) * 2000-12-06 2002-06-18 Robert J Hariri Method of collecting placental stem cells background of the invention
ES2558626T3 (en) * 2001-02-14 2016-02-05 Anthrogenesis Corporation Placenta post-partum of mammals, their use and placental stem cells thereof
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
US7807458B2 (en) 2003-01-30 2010-10-05 The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs Multilineage-inducible cells and uses thereof
US7603154B2 (en) * 2003-04-24 2009-10-13 Koninklijke Philips Electronics N.V. Non-invasive left ventricular volume determination
AT482713T (en) * 2003-04-25 2010-10-15 Univ Pittsburgh Muscle - delivering cells (mdcs) to promote and improve nerve repair and regeneration
EP1747265B1 (en) * 2004-04-23 2011-04-20 BioE LLC Multi-lineage progenitor cells
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
KR101322889B1 (en) 2004-08-16 2013-10-30 셀리서치 코포레이션 피티이 리미티드 Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US9234897B2 (en) * 2005-03-31 2016-01-12 Two Cells Co., Ltd Method for distinguishing mesenchymal stem cell using molecular marker and use thereof
US8153430B2 (en) 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
US8871198B2 (en) * 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US20060252149A1 (en) * 2005-05-06 2006-11-09 Orion Biosolutions, Inc. Cns cells in vitro
US20070059824A1 (en) * 2005-09-12 2007-03-15 Yong Zhao Human umbilical cord blood-derived pluripotent fibroblast-like-macrophages
ES2454021T3 (en) 2005-10-05 2014-04-09 The Board Of Trustees Of The University Of Illinois Embryonic type stem cells isolated from human umbilical cord blood
US9388382B2 (en) * 2005-10-05 2016-07-12 The Board Of Trustees Of The University Of Illinois Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
PE20110020A1 (en) 2005-10-13 2011-01-31 Anthrogenesis Corp Immunomodulation using placental stem cells
US8287854B2 (en) 2005-10-21 2012-10-16 Cellresearch Corporation Pte Ltd Skin equivalents derived from umbilical cord mesenchymal stem/progenitor cells and umbilical cord epithelial stem/progenitor cells
US9265792B2 (en) * 2005-11-16 2016-02-23 Patricia A. Riley Integument cell regeneration formulation
WO2007071048A1 (en) 2005-12-22 2007-06-28 Jane Ennis Viable cells from frozen umbilical cord tissue
CN103060263B (en) * 2005-12-29 2016-03-16 人类起源公司 Placental stem cell populations
US8455250B2 (en) 2005-12-29 2013-06-04 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
EP2019858B1 (en) * 2006-04-17 2012-06-13 BioE LLC Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
AU2007243221A1 (en) * 2006-04-28 2007-11-08 Tulane University Health Sciences Center Methods for treating diabetes
BRPI0710339A2 (en) * 2006-05-05 2011-08-09 Jane Ennis modulation method of an immunological reaction, reduction method and extract
FR2901136B1 (en) * 2006-05-18 2010-10-01 Centre Nat Rech Scient Use of cells derived from adipose tissue for the preparation of an anti-tumor drug
US20080050814A1 (en) * 2006-06-05 2008-02-28 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of fetal placental cells
US20080064098A1 (en) * 2006-06-05 2008-03-13 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
ZA200810412B (en) * 2006-06-09 2010-03-31 Anthrogenesis Corp Placental niche and use thereof to culture stem cells
WO2007145889A1 (en) 2006-06-14 2007-12-21 Stemnion, Inc. Methods of treating spinal cord injury and minimizing scarring
US20070298497A1 (en) * 2006-06-26 2007-12-27 Gambro Bct, Inc. Method of Culturing Mesenchymal Stem Cells
EP2089510A4 (en) * 2006-06-28 2010-05-19 Univ New Jersey Med Amnion-derived stem cells and uses thereof
US20080025953A1 (en) * 2006-07-25 2008-01-31 Kiminobu Sugaya Vigor Enhancement of Animals Via Administration of Stem Cells
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
WO2008048671A1 (en) * 2006-10-18 2008-04-24 University Of Illinois Embryonic-like stem cells derived from adult human peripheral blood and methods of use
US20100143289A1 (en) * 2006-12-19 2010-06-10 Michael Cohen Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
US8221741B2 (en) 2007-01-17 2012-07-17 Marshall Vivienne S Methods for modulating inflammatory and/or immune responses
US8506949B2 (en) 2007-01-17 2013-08-13 Stemnion, Inc. Methods for modulating inflammatory and/or immune responses
NZ597779A (en) 2007-02-12 2013-07-26 Anthrogenesis Corp Treatment of inflammatory diseases using placental stem cells
JP2008206500A (en) 2007-02-28 2008-09-11 Kitasato Institute Method for producing tooth and tooth obtained by the same
US8383349B2 (en) 2007-03-16 2013-02-26 The Board Of Trustees Of The Leland Stanford Junior University Bone morphogenetic protein antagonist and uses thereof
WO2009008928A2 (en) * 2007-04-13 2009-01-15 Stemnion, Inc. Methods for treating nervous system injury and disease
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
EP2192908A4 (en) * 2007-07-25 2010-09-01 Bioe Inc Differentiation of multi-lineage progenitor cells to chondrocytes
US20090054339A1 (en) * 2007-08-22 2009-02-26 Marshall Vivienne S Novel cellular factor-containing solution compositions
KR101039235B1 (en) * 2007-08-29 2011-06-07 메디포스트(주) Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-?, comprising UCB-MSCs
KR20150088336A (en) 2007-09-28 2015-07-31 안트로제네시스 코포레이션 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
WO2009065093A2 (en) * 2007-11-17 2009-05-22 University Of Medicine And Dentistry Of New Jersey Use of stem cells for wound healing
RU2384618C2 (en) * 2008-03-27 2010-03-20 Общество С Ограниченной Ответственностью "Лаборатория Клеточных Технологий" Method for making fibroblast-like cells of umbilical cord of newborn
WO2009129616A1 (en) 2008-04-21 2009-10-29 Tissue Regeneration Therapeutics, Inc. Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
US20090275011A1 (en) * 2008-04-30 2009-11-05 Johann Eibl Sessile stem cells
KR101237430B1 (en) * 2008-05-07 2013-02-26 남명진 A cosmetic composition comprising stem cell culture medium and a process for producing the same
US20110065605A1 (en) * 2008-05-14 2011-03-17 Eth Zurich Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
WO2009143241A2 (en) * 2008-05-21 2009-11-26 Bioe, Inc. Differentiation of multi-lineage progenitor cells to pancreatic cells
US20100028307A1 (en) * 2008-07-31 2010-02-04 O'neil John J Pluripotent stem cell differentiation
WO2010022083A2 (en) * 2008-08-18 2010-02-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
JP6169316B2 (en) 2008-08-20 2017-07-26 アンスロジェネシス コーポレーション Improved cell composition and method for producing the same
KR20190122891A (en) * 2008-08-20 2019-10-30 안트로제네시스 코포레이션 Treatment of stroke using isolated placental cells
PE20110358A1 (en) 2008-08-22 2011-06-13 Anthrogenesis Corp Methods and compositions for the treatment of bone defects with placental cell populations
CN107201337A (en) 2008-11-19 2017-09-26 人类起源公司 Amnion-derived attached cell
KR101218101B1 (en) * 2009-03-20 2013-01-03 주식회사 스템메디언스 Compositions for Promoting Hair Growth Using Fetus-derived Mesenchymal Stem Cells from Amniotic Fluids
BR112012001107A2 (en) * 2009-07-09 2015-09-01 Janssen Biotech Inc Cells derived from cardiac tissue
TR201809713T4 (en) * 2009-08-25 2018-07-23 Servicio Andaluz De Salud By using agarose-fibrin biomaterial tissue engineering artificial tissues AmAlArInI production.
CA2774612C (en) 2009-09-23 2019-09-03 Davinci Biosciences Llc Umbilical cord lining stem cells and methods and material for isolating and culturing same
BR112012010750A2 (en) 2009-11-05 2019-09-24 Johny Yung Chiong Chow human germ stem cell storage system
EP2498798A4 (en) * 2009-11-10 2014-01-01 Univ Columbia Compositions and methods for wound treatment
US20110223138A1 (en) * 2009-12-17 2011-09-15 Prockop Darwin J Mesenchymal stem cells that express increased amounts of anti-apoptotic proteins
CN102822330A (en) 2010-01-26 2012-12-12 人类起源公司 Treatment of bone-related cancers using placental stem cells
US8906685B2 (en) 2010-01-28 2014-12-09 The Regents Of The University Of Michigan Hanging drop devices, systems and/or methods
EP2533859B1 (en) * 2010-02-10 2016-04-06 Nayacure Therapeutics Ltd Pharmaceutical compositions for the treatment and prevention of cancer
EP2556145B1 (en) 2010-04-07 2016-07-20 Anthrogenesis Corporation Angiogenesis using placental stem cells
CN102933221A (en) 2010-04-08 2013-02-13 人类起源公司 Treatment of sarcoidosis using placental stem cells
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2011151043A1 (en) * 2010-06-01 2011-12-08 Trauma Care Consult (Tcc) Traumatologische Forschung Gemeinnuetzige Gesellschaft Mbh Process for differentiating stem cells of the amniotic membrane
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
JP5996533B2 (en) 2010-07-13 2016-09-21 アントフロゲネシス コーポレーション How to generate natural killer cells
KR101211913B1 (en) 2010-07-16 2012-12-13 주식회사 알앤엘바이오 Medium for Culturing Mesenchymal Stem Cells Derived from Amnion and Method for Culturing Mesenchymal Stem Cells Derived from Amnion Using thereof
JP2012031127A (en) * 2010-08-03 2012-02-16 Nagoya Univ Composition including umbilical cord matrix stromal cell
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
PL2714059T3 (en) 2011-06-01 2019-04-30 Celularity, Inc. Treatment of pain using placental stem cells
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
CN103055348A (en) * 2011-10-24 2013-04-24 北京清美联创干细胞科技有限公司 Preparation method and application of autologous mesenchymal stem cell-loaded human amniotic membrane cornea paster
WO2013102219A1 (en) * 2011-12-30 2013-07-04 Amit Patel Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses
US8940294B2 (en) 2012-03-02 2015-01-27 Tissuetech, Inc. Methods of isolating and culturing stem cells
JP5931277B2 (en) 2012-04-13 2016-06-08 アール バイオ カンパニー リミテッドR Bio Co., Ltd. Method and composition for preventing disruption and aggregation of stem cells
BR112014025931A2 (en) 2012-04-18 2017-07-11 Chan Ra Jeong method for making stem cells of appropriate size for intravascular administration
KR101523040B1 (en) 2012-06-26 2015-05-26 라정찬 Method for Preparing High Concentration of Stem Cells
WO2014110560A1 (en) * 2013-01-14 2014-07-17 The General Hospital Corporation Il-18 inhibition for promotion of early hematopoietic progenitor expansion
WO2014123879A1 (en) 2013-02-05 2014-08-14 Anthrogenesis Corporation Natural killer cells from placenta
WO2014132936A1 (en) * 2013-02-28 2014-09-04 国立大学法人 富山大学 Method for selectively amplifying placental or periplacental tissue stem cells
EP2968402A4 (en) 2013-03-13 2016-12-21 Stemnion Inc Improved medical device
KR20150143625A (en) 2013-04-16 2015-12-23 오르브센 테라퓨틱스 리미티드 Medical use of syndecan-2
KR101588394B1 (en) 2013-05-09 2016-01-25 라정찬 Media Composition for Improving Renewal Ability and Method for Culturing Stem Cells Using the Same
KR101583569B1 (en) 2013-05-15 2016-01-08 라정찬 Composition for Intravenous Administration Comprising Stem Cells
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
RU2554843C2 (en) * 2013-08-08 2015-06-27 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Д.Гольдберга" (НИИФиРМ им.Е.Д.Гольдберга) Method for producing and inducing targeted differentiation of pulmonary pluripotent cell culture
WO2015170347A2 (en) * 2014-05-09 2015-11-12 Reelabs Private Limited Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders
US20170119824A1 (en) * 2014-05-24 2017-05-04 Neelam Krishnan Venkataramanaa A method for the treatment of glioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord
US9913466B2 (en) 2014-09-10 2018-03-13 Healthbanks Biotech Co. Ltd. Cryopreservation of umbilical cord tissue strips for cord tissue-derived stem cells
CA2968048A1 (en) 2014-10-29 2016-05-06 R Bio Co., Ltd. Medium composition for culturing stem cells
WO2016150884A1 (en) 2015-03-20 2016-09-29 Orbsen Therapeutics Limited Modulators of syndecan-2 and uses thereof
CA2986702A1 (en) 2015-05-21 2016-11-24 David Wang Modified demineralized cortical bone fibers
RU2620981C2 (en) * 2015-11-18 2017-05-30 Общество с ограниченной ответственностью "Покровский банк стволовых клеток" Method of obtaining the culture of mesenchymal human stem cells from the perivascular space of the vein of umbilical cord
CN105497983A (en) * 2015-12-15 2016-04-20 天津市康婷生物工程有限公司 Simple and efficient preparation method of stem cell patch
TWI586804B (en) * 2016-02-19 2017-06-11 生寶生物科技股份有限公司 Cryopreservation of umbilical cord tissue strips for cord tissue-derived stem cells
CA3031978A1 (en) * 2016-10-05 2018-04-12 Cellresearch Corporation Pte. Ltd. A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium
WO2019199229A1 (en) * 2018-04-09 2019-10-17 Cellresearch Corporation Pte. Ltd. A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds
WO2019199230A1 (en) * 2018-04-09 2019-10-17 Cellresearch Corporation Pte. Ltd. A method of transporting mesenchymal stem cells by means of a cell culture medium and a method of administering stem cells to wounds
WO2019199234A1 (en) * 2018-04-12 2019-10-17 Cellresearch Corporation Pte. Ltd. A method of inducing or improving wound healing properties of mesenchymal stem cells
RU2710263C1 (en) * 2019-09-19 2019-12-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method for producing and culturing fibroblast-like cells from a newborn's umbilical cord

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5744347A (en) 1987-01-16 1998-04-28 Ohio University Edison Biotechnology Institute Yolk sac stem cells and their uses
GB8803697D0 (en) 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
SE9402528D0 (en) 1994-07-19 1994-07-19 Astra Ab Hard Tissue Stimulation with electricity
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5665557A (en) 1994-11-14 1997-09-09 Systemix, Inc. Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
PT793714E (en) 1994-11-16 2002-12-31 Amgen Inc Use of the factor of stem cells and the interleucin 6 receptor soluable for the ex expansion of multi-potential hematophouse cells
CN1127638A (en) 1995-01-26 1996-07-31 黄裕泉 Process for extraction of pure active holo-man-placenta extract
WO1996023003A1 (en) 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
US5591444A (en) 1995-07-28 1997-01-07 Isolagen Technologies, Inc. Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
JP2000508922A (en) 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ Skin regeneration using mesenchymal stem cells
US6054142A (en) 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US5919702A (en) 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
US5919808A (en) * 1996-10-23 1999-07-06 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US6638763B1 (en) 1997-01-07 2003-10-28 University Of Tennessee Research Foundation Isolated mammalian neural stem cells, methods of making such cells
WO1998030679A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
AU4860900A (en) * 1999-06-02 2000-12-18 Lifebank Services, L.L.C. Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
AUPQ259399A0 (en) 1999-09-01 1999-09-23 Lustre Investments Pte Ltd Therapeutic agents
CA2476553A1 (en) 2002-02-13 2003-08-21 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
NZ527849A (en) 2001-02-14 2006-09-29 Anthrogenesis Corp Post-partum mammalian placenta, its use and placental stem cells therefrom
US20030044977A1 (en) * 2001-08-10 2003-03-06 Norio Sakuragawa Human stem cells originated from human amniotic mesenchymal cell layer
EP1288293A1 (en) * 2001-08-30 2003-03-05 Norio Sakuragawa Human neural stem cells originated from human amniotic mesenchymal cell layer
EP1442115B9 (en) 2001-11-15 2009-12-16 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
JP3728750B2 (en) 2001-11-22 2005-12-21 ニプロ株式会社 Cultured skin and method for producing the same
JP2003231639A (en) 2001-12-06 2003-08-19 Toshio Nikaido Pharmaceutical composition containing cell derived from human amnion
AU2002354101A1 (en) 2001-12-06 2003-06-17 Sankyo Company, Limited Medicinal compositions containing human amnion-origin cells
KR20030050168A (en) 2001-12-18 2003-06-25 김정철 Bioartificial skin prepared from mesenchymal cells of hair follicle
EP1483371B1 (en) 2002-02-19 2007-06-27 Medipost, Co., Ltd. Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
CA2483010A1 (en) * 2002-04-19 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Placental derived stem cells and uses thereof
JP2005139067A (en) 2002-09-09 2005-06-02 Toshio Nikaido Human amnion-originated cell-containing medicine composition for treating cardiac disease
JP2004121419A (en) * 2002-09-30 2004-04-22 Nipro Corp Cultured skin containing umbilical cord epitheliocyte
DE602004028803D1 (en) * 2003-02-11 2010-10-07 John E Davies Precursor cells from the wharton sulce of human neck locks
AU2004252570C1 (en) 2003-06-27 2012-03-01 Ethicon, Incorporated Soft tissue repair and regeneration using postpartum-derived cells
EP1639099B1 (en) 2003-06-27 2011-05-18 Université Laval Method of isolating cells from umbilical cord
JP2005151907A (en) * 2003-11-27 2005-06-16 Hayakawa Yasuhiko Human stem cell derived from placenta or amnion and method for establishing the same and method for differentiation-induction to organ
KR101322889B1 (en) 2004-08-16 2013-10-30 셀리서치 코포레이션 피티이 리미티드 Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
US8287854B2 (en) 2005-10-21 2012-10-16 Cellresearch Corporation Pte Ltd Skin equivalents derived from umbilical cord mesenchymal stem/progenitor cells and umbilical cord epithelial stem/progenitor cells

Also Published As

Publication number Publication date
MX2007001937A (en) 2007-08-07
RU2007109452A (en) 2008-09-27
DK1789534T3 (en) 2014-11-17
NZ553695A (en) 2009-10-30
US9844571B2 (en) 2017-12-19
AU2005273077A1 (en) 2006-02-23
JP2008509699A (en) 2008-04-03
US9737568B2 (en) 2017-08-22
RU2416638C2 (en) 2011-04-20
BRPI0514387A (en) 2008-06-10
GB0704640D0 (en) 2007-04-18
CA2577447A1 (en) 2006-02-23
EP1789534A1 (en) 2007-05-30
HK1104061A1 (en) 2008-05-30
JP5798546B2 (en) 2015-10-21
TW200613556A (en) 2006-05-01
CA2971062C (en) 2019-02-26
GB2432166A (en) 2007-05-16
US20060078993A1 (en) 2006-04-13
TWI312009B (en) 2009-07-11
AU2005273077B2 (en) 2011-02-24
JP2013066473A (en) 2013-04-18
EP1789534A4 (en) 2008-03-05
EP2597149A1 (en) 2013-05-29
CA2577447C (en) 2017-08-01
ES2527293T3 (en) 2015-01-22
KR101322889B1 (en) 2013-10-30
US20160024466A1 (en) 2016-01-28
US10322148B2 (en) 2019-06-18
EP1789534B1 (en) 2014-08-06
US20180000866A1 (en) 2018-01-04
GB2432166B (en) 2008-01-02
CA2971062A1 (en) 2006-02-23
MY141772A (en) 2010-06-30
US9085755B2 (en) 2015-07-21
US20160250257A1 (en) 2016-09-01
US20190290699A1 (en) 2019-09-26
US20130337563A1 (en) 2013-12-19
KR20070053255A (en) 2007-05-23
US10363275B2 (en) 2019-07-30
PL1789534T3 (en) 2015-03-31
JP5668208B2 (en) 2015-02-12
WO2006019357A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
Kim et al. Human amniotic fluid‐derived stem cells have characteristics of multipotent stem cells
Prusa et al. Neurogenic cells in human amniotic fluid
Wanet et al. Connecting mitochondria, metabolism, and stem cell fate
Oh et al. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells
Cheng et al. Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture
Tondreau et al. Bone marrow–derived mesenchymal stem cells already express specific neural proteins before any differentiation
Pappa et al. Novel sources of fetal stem cells: where do they fit on the developmental continuum?
Ogura et al. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine
Revazova et al. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts
Tong et al. Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method
Inzunza et al. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells
DK1342780T3 (en) Improved method for culturing mammalian cells in vitro
EA200870204A1 (en) Systems and methods of production of biofuels and related materials
IL181437D0 (en) Medium and culture of embryonic stem cells
NZ567082A (en) Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
TR201809759T4 (en) Stem cell culture medium and procedure.
WO2005086845A3 (en) Compositions and methods for growth of embryonic stem cells
NZ592726A (en) Amnion derived adherent cells
SG166770A1 (en) Use of adipose tissue-derived stromal stem cells in treating fistula
ES2721174T3 (en) Improved modalities for the treatment of degenerative diseases of the retina
CA2530416A1 (en) Postpartum cells derived from placental tissue, and methods of making and using the same
WO2005047524A3 (en) Compositions and methods for inducing cell dedifferentiation
MX2009008559A (en) Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations.
SG177705A1 (en) Pluripotent stem cell that can be isolated from body tissue
GB0803474D0 (en) Compositions and methods for growth of pluripotent cells

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed